Patent directory · USPTO A61K / A61P
Patents matching “ReveraGen BioPharma, Inc.”
15 pharma patents match "ReveraGen BioPharma, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 15 pharmaceutical patents matching "ReveraGen BioPharma, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12201639
Aqueous oral pharmaceutical suspension compositions
granted -
US 11833159
Non-hormonal steroid modulators of NF-kB for treatment of disease
granted -
US 11690853
Non-hormonal steroid modulators of NF-κβ for treatment of disease
granted -
US 11471471
Aqueous oral pharmaceutical suspension compositions
granted -
US 11382922
Aqueous oral pharmaceutical suspension compositions
granted -
US 10857161
Non-hormonal steroid modulators of NF-kB for treatment of disease
granted -
US 10799514
Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
granted -
US 10464967
Non-hormonal steroid modulators of NF-κβ for treatment of disease
granted -
US 10206933
Non-hormonal steroid modulators of NF-kB for treatment of disease
granted -
US 10000525
Non-hormonal steroid modulators of NF-κB for treatment of disease
granted -
US 9649320
Non-hormonal steroid modulators of NF-κB for treatment of disease
granted -
US 9637738
Methods and agents to increase therapeutic dystrophin expression in muscle
granted -
US 9434758
Non-hormonal steroid modulators of NF-κB for treatment of disease
granted -
US 9198921
Non-hormonal steroid modulators of NF-κB for treatment of disease
granted -
US 8673887
Non-hormonal steroid modulators of NF-kB for treatment of disease
granted